PTK2 and cancer: Cancer-associated proteins such as Ephrin receptor A2, Aurora-A, and FAK have been identified as critical targets for cancer therapy, with FAK being implicated in epigenetic modifications, genomic instability, and epithelial-mesenchymal transition, all of which contribute to metastasis [11].